Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T14:30:27.049Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T14:30:27.049Z.
Quote observation: 2026-10-06T14:29:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b909c1583fef9061a4d716d1bfa7e8c39158eca830282836b9decd9e758125
FORWARD PE RATIO
N/A
Akanda Corp.
Market Cap
$61981.00
Forward PE Ratio
N/A
Market Cap
$31124.00
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Akanda Corp. (AKAN) | $61981.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $31124.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6273.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $399041.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $564917.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $676545.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827771.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $867108.00 | N/A |
| Bone Biologics Corporation (BBLG)vs › | $874595.00 | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
